114 related articles for article (PubMed ID: 11038767)
1. [Clinical significance of p21H-ras expression and H-ras codon 12 mutation in squamous intraepithelial lesion (SIL) and carcinoma of uterine cervix].
Li X; Jiao S; Mi R
Zhonghua Zhong Liu Za Zhi; 1997 Jul; 19(4):306-8. PubMed ID: 11038767
[TBL] [Abstract][Full Text] [Related]
2. Expression and mutation of H-ras in uterine cervical cancer.
Lee JH; Lee SK; Yang MH; Ahmed MM; Mohiuddin M; Lee EY
Gynecol Oncol; 1996 Jul; 62(1):49-54. PubMed ID: 8690291
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional activation of H- and N-ras oncogenes in human cervical cancer.
Mammas IN; Zafiropoulos A; Koumantakis E; Sifakis S; Spandidos DA
Gynecol Oncol; 2004 Mar; 92(3):941-8. PubMed ID: 14984964
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of ras oncogenes in CIN III and in stage I and II invasive squamous cell carcinoma of the uterine cervix.
O'Leary JJ; Landers RJ; Silva I; Uhlmann V; Crowley M; Healy I; Luttich K
J Clin Pathol; 1998 Aug; 51(8):576-82. PubMed ID: 9828814
[TBL] [Abstract][Full Text] [Related]
5. Absence of point mutation in codons 12 and 13 of K-RAS oncogene in HPV-associated high grade dysplasia and squamous cell cervical carcinoma.
Pochylski T; Kwaśniewska A
Eur J Obstet Gynecol Reprod Biol; 2003 Nov; 111(1):68-73. PubMed ID: 14557015
[TBL] [Abstract][Full Text] [Related]
6. Detection of HPV and ras gene mutations in cervical smears from female genital lesions.
Dokianakis DN; Sourvinos G; Sakkas S; Athanasiadou E; Spandidos DA
Oncol Rep; 1998; 5(5):1195-8. PubMed ID: 9683834
[TBL] [Abstract][Full Text] [Related]
7. Codon 72 polymorphism of p53 as a risk factor for patients with human papillomavirus-associated squamous intraepithelial lesions and invasive cancer of the uterine cervix.
Yamashita T; Yaginuma Y; Saitoh Y; Kawai K; Kurakane T; Hayashi H; Ishikawa M
Carcinogenesis; 1999 Sep; 20(9):1733-6. PubMed ID: 10469618
[TBL] [Abstract][Full Text] [Related]
8. H-ras codon 12 mutation in cervical dysplasia.
Van Le L; Stoerker J; Rinehart CA; Fowler WC
Gynecol Oncol; 1993 May; 49(2):181-4. PubMed ID: 8389312
[TBL] [Abstract][Full Text] [Related]
9. [Detection and clinical pathological significance of the expression of P21, P185, p53 proteins and mutation of ras, p53 genes in transitional cell carcinoma of the bladder].
Yu D; Liu F; Liang Z
Zhonghua Bing Li Xue Za Zhi; 1996 Aug; 25(4):202-5. PubMed ID: 9275651
[TBL] [Abstract][Full Text] [Related]
10. Immunophenotype of mutant ras p21 and early response to radiotherapy in cancer of the uterine cervix.
Sreelekha TT; Nair MK; Jayaprakash PG; Pillai MR
J Exp Clin Cancer Res; 1999 Sep; 18(3):337-41. PubMed ID: 10606179
[TBL] [Abstract][Full Text] [Related]
11. Ras oncogene expression and progression in intraepithelial neoplasia of the uterine cervix.
Sagae S; Kudo R; Kuzumaki N; Hisada T; Mugikura Y; Nihei T; Takeda T; Hashimoto M
Cancer; 1990 Jul; 66(2):295-301. PubMed ID: 2196111
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance on expression of the ras gene product P21 in human cervical carcinoma tissues].
Huang G; Lu S; Mao T; Song Y
Hua Xi Yi Ke Da Xue Xue Bao; 1992 Mar; 23(1):61-4. PubMed ID: 1398628
[TBL] [Abstract][Full Text] [Related]
13. K-ras mutations and HPV infection in cervicitis and intraepithelial neoplasias of the cervix.
Prokopakis P; Sourvinos G; Koumantaki Y; Koumantakis E; Spandidos DA
Oncol Rep; 2002; 9(1):129-33. PubMed ID: 11748470
[TBL] [Abstract][Full Text] [Related]
14. H-ras and Nm23-H1 gene expression and proteolytic activity in squamous cell carcinoma of the uterine cervix.
Utrera-Barillas D; Salcedo-Vargas M; Gariglio-Vidal P; Hernández-Hernández DM; Gutiérrez-Delgado F; Benítez-Bribiesca L
Arch Med Res; 2000; 31(2):172-81. PubMed ID: 10880723
[TBL] [Abstract][Full Text] [Related]
15. ras and c-myc oncoproteins during tumor progression in the uterine cervix.
Nair SA; Nair MB; Jayaprakash PG; Rajalekshmy TN; Nair MK; Pillai MR
Tumori; 1998; 84(5):583-8. PubMed ID: 9862521
[TBL] [Abstract][Full Text] [Related]
16. Uterine cervical dysplasia and cancer: identification of c-myc status by quantitative polymerase chain reaction.
Aoyama C; Peters J; Senadheera S; Liu P; Shimada H
Diagn Mol Pathol; 1998 Dec; 7(6):324-30. PubMed ID: 10207671
[TBL] [Abstract][Full Text] [Related]
17. [Death-associated protein kinase promoter (DAPK) hypermethylation in uterine cervical cancer and intraepithelial neoplasia in Uyghur nationality women].
Niyazi M; Liu XW; Zhu KC
Zhonghua Zhong Liu Za Zhi; 2012 Jan; 34(1):31-4. PubMed ID: 22490852
[TBL] [Abstract][Full Text] [Related]
18. [Expression and clinical significance of Dyrk1b in the specimens and cells of cervical lesions].
Lin J; Zhang P; Pang L; Chen J; Sun W; Qi W; Lyu Y; Guan H; Gao J
Zhonghua Fu Chan Ke Za Zhi; 2016 Jan; 51(1):40-5. PubMed ID: 26899006
[TBL] [Abstract][Full Text] [Related]
19. Relationships between c-Ki-ras mutations, HPV types, and prognostic indicators in invasive endocervical adenocarcinomas.
Koulos JP; Wright TC; Mitchell MF; Silva E; Atkinson EN; Richart RM
Gynecol Oncol; 1993 Mar; 48(3):364-9. PubMed ID: 8385060
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of p53 and p21 in low grade cervical squamous intraepithelial lesions infected with low, intermediate, and high risk human papillomaviruses.
Giannoudis A; Herrington CS
Cancer; 2000 Sep; 89(6):1300-7. PubMed ID: 11002226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
